Symptom experience associated with maintenance immunosuppression after heart transplantation: Patients' appraisal of side effects

Heart and Lung: Journal of Acute and Critical Care

Volumn 27, Issue 5, 1998, Pages 315-325

  Moons, Philip ^a   De Geest, Sabina ^a,b   Abraham, Ivo ^a,c   Van Cleemput, Johan ^b   Vanhaecke, Johan ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISOLONE;

ACNE; ADULT; AGED; ARTICLE; DEPRESSION; FEMALE; GASTROINTESTINAL TOXICITY; GRAFT VERSUS HOST REACTION; HEADACHE; HEART PALPITATION; HEART TRANSPLANTATION; HIRSUTISM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPOTENCE; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; PRIORITY JOURNAL; SKIN TOXICITY; VISUAL IMPAIRMENT;

EID: 0031688015     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9563(98)90052-8     Document Type: Article

References (31)

1. Bernabeu M, Krupp P, Wiskott E. Long-term safety of cyclosporine in renal transplant recipients: worldwide experience. Transplant Proc 1993;25:17-9.
2. Kahan BD, Flechner SM, Lorber MI, Golden D, Conley S, Van Buren CT. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years. Transplantation 1987;43:197-204.
3. Seale JP, Compton MR. Side-effects of corticosteroid agents. Med J Aust 1986;144:139-42.
4. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med 1996;334:35-40.
5. Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res 1992;16: 143-63.
6. Didlake RH, Dreyfus K, Kerman RH, Van Buren CT, Kahan BD. Patient non-compliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc 1988;10(suppl.3):63-9.
7. Schweitzer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Non-compliance in organ transplant recipients. Transplantation 1990;49:374-7.
8. Sketris I, Grobler M, West M, Gerus S. Factors affecting compliance with cyclosporine in adult renal transplant recipients. Transplant Proc 1994;26:2538-41.
9. Rhodes VA, Watson PM. Symptom distress, the concept: past and present. Semin Oncol 1987;3:242-7.
10. Pennebaker JW. The psychology of physical symptoms. New York: Springer Verlag; 1982.p.1-57.
11. Persson L, Sjörberg L. Mood and somatic symptoms. J Psychosom Res 1987;31:499-511.
12. Gijsbers van Wijk CM, Kolk AM, van den Bosch WJ, van den Hoogen HJ. Male and female morbidity in general practice: the nature of sex differences. Soc Sci Med 1992;35:665-78.
13. Baumann LJ, Young CJ, Egan JJ. Living with a heart transplant: long-term adjustment. Transpl Int 1992;5:1-8.
14. Foley TC, Davis CP, Conway PA. Liver transplant recipients-self-report of symptom frequency, symptom distress, quality of life. Transplant Proc 1989;21:2417-8.
15. Jones BM, Taylor FJ, Wright OM, Harvison A, McBride M, Spratt PM, et al. Quality of life after heart transplantation in patients assigned to double- or triple-drug therapy. J Heart Transplant 1990;9:392-6.
16. Lough ME, Lindsey AM, Shinn JA, Stotts NA. Life satisfaction following heart transplantation. J Heart Transplant 1985;4: 446-9.
17. Lough ME, Lindsey AM, Shinn JA, Stotts NA. Impact of symptom frequency and symptom distress on self-reported quality of life in heart transplant recipients. Heart Lung 1987;16:193-200.
18. De Geest S, Borgermans L, Gemoets H, Abraham I, Vlaminck H, Evers G, et al. Incidence, determinants, and consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995;59:340-7.
19. Jalowiec A, Grady KL, White-Williams C, Fazekas S, Laff M, Davidson-Bell V, et al. Symptom distress three months after heart transplantation. J Heart Lung Transplant 1997;16:604-14.
20. Daley TD, Wysocki GP, Day C. Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986;62:417-21.
21. Braith RW, Limacher MC, Leggett SH, Pollock ML. Skeletal muscle strength in heart transplant recipients. J Heart Lung Transplant 1993;12:1018-23.
22. Polit DF, Hungler BR Nursing research: principles and methods. 4th ed. Philadelphia: JB Lippincott; 1991.p. 373.
23. De Geest S, Abraham I, Vanhaecke J. Clinical risk associated with appointment noncompliance in heart transplant recipients. Circulation 1996;(Abstr Suppl): I-180.
24. De Geest S, Abraham I, Vanhaecke J. Comparison of patient characteristics of clinical noncompliers and clinical compliers with immunosuppressive therapy after heart transplantation. Eur Heart J 1996;(Abstr Suppl):37.
25. Bross IDJ. How to use ridit analysis. Biometrics 1958;14:18-38.
26. Sermeus W, Delesie L. Ridit analysis on ordinal data. West J Nurs Res 1996;18:351-9.
27. Steiger MJ, Farrah T, Rolles K, Harvey P, Burroughs AK. Cyclosporin associated headache. J Neurol Neurosurg Psychiatry 1994;57:1258-9.
28. Hilbrands LB, Andries JH, Koene RAP. The effect of immunosuppressive drugs on quality of life after renal transplantation. Transplantation 1995;59:1263-70.
29. Lieban RW. Gender and symptom sensitivity: report on a Philippine study. Am J Orthopsychiatry 1985;55:446-50.
30. Verbrugge LM. Gender and health: an update on hypotheses and evidence. J Health Soc Beh 1985;26:156-82.
31. Quality of life and clinical trials [editorial]. Lancet 1995;346:1-2.